South Florida Hospital News
Friday December 14, 2018
Quote

test 2

January 2018 - Volume 14 - Issue 7

Subscribe

Advertisements

NovaMPH.jpg

http://dannagracey.com/

Helping Oncologists Treat the Disease While Palliative and Hospice Services Treat the Patient

Since the emergence of the hospice programs in 1982, cancer treatment has undergone sweeping changes and advancements, marked by hundreds of new cancer drugs and biologics, genetic technologies, targeted therapies, greater access to clinical trials, and massive investments in cancer treatment centers.

Compared with cancer patients 35 years, ago, 2018 patients are more likely to survive and emerge from treatment cancer-free, or more likely to function and live at home with cancer for months or years—a trend that presents challenges to hospice services and their focus on end-of-life care.
 
Still, cancer continues to represent the most common condition for hospice services, and close to 30 percent of all hospice patients receive care for seven days or fewer, according to the National Hospice and Palliative Care Organization (NHPCA). VITAS Healthcare, the leading provider of hospice care in South Florida and the nation, feels that seven days is too little too late, undervaluing the benefits of comfort-focused palliative care and undermining patients’ desires for a dignified, pain-free death when cancer no longer responds as hoped to curative treatment.
 
Against this backdrop, VITAS has updated its approach to cancer-specific palliative and hospice care. VITAS is providing more services, and we are continuously updating our ability to provide data that satisfies emerging standards of care for oncology certification and reimbursement.
 
A terminal diagnosis opens the door for innovative hospice solutions
VITAS’s cancer-specific solutions include:
• A team approach to cancer care, informed by a goals-of-care plan crafted by the patient, family/caregiver and their VITAS team, which may include a physician, nurse, social worker, hospice aide, chaplain and bereavement specialist and volunteer
• An Oncology Task Force of VITAS physicians and pharmacists who review each cancer referral and make real-time decisions about treatments and medications, based on the patient’s end-of-life goals and expectations
• A specialized team that initiates advance-directive and end-of-life conversations with patients in cooperation with the patient’s oncologist or PCP
• Optional holistic approaches that address symptoms and improve quality of life, including reiki, acupuncture, aromatherapy, pet visits, music therapy and more
 
Curative: a definition worth exploring
VITAS is able to continue treatments or interventions that other hospice providers might discontinue. As a rule, all curative treatments for a terminal disease are halted once a patient is referred to hospice. But with proper documentation and justification, VITAS supports the use of medications and interventions for terminally ill cancer patients if doing so:
• provides pain and symptom relief
• improves the quality of life
• prevents adverse side effects or events
• maintains awareness and cognition as death nears
 
Example: VITAS might continue radiation treatment for a patient with advanced cancer, or continue Lupron for a patient with end-stage prostate cancer, if the intervention relieves severe pain, avoids the use of morphine/opioids, or prevents the severe muscle-wasting effects of cortisone and other medications.
 
Our message to cancer patients: “We can’t cure your disease, but we can address your symptoms based on what’s important to you, your family and your quality of life.”
 
A clearer path for hospitals, too
VITAS delivers a similar message about palliative care to area hospitals, cancer specialists and oncology groups: “While you are treating the cancer, let us address the person and their symptoms.”
 
And when curative treatments are no longer effective, a VITAS team handles the medical, emotional and spiritual issues that are prevalent near the end of life. This can include management of symptoms specific to the cancer or its treatment, as well as the psychosocial effects of grief, loss of meaning, income, family role and more.
 
The VITAS approach also complements industry changes in oncology certification and reimbursement. The American Society of Clinical Oncology, for example, now requires documentation of palliative care services for certification. Likewise, other quality-of-care initiatives are tying cancer-related reimbursement to outcome measures that assess such factors as the length of time between a patient’s last chemotherapy dose and death, or the presence of advance directives in the cancer care plan. VITAS can provide both the solutions and metrics that make meeting these higher standards possible.
 
Hand-in-hand: oncology care and hospice
Too many times, after several weeks on already-delayed hospice care, cancer patients will say to me, “I wish I had received these services three months ago, or six months or nine months ago.”
Cancer treatment, palliative care and hospice care can and should go hand-in-hand, for the benefit of the patients, their families, and the hospitals and physicians who treat them. VITAS is well positioned to be an expert and innovative partner for South Florida hospitals and specialists in their treatment of patients with cancer.
 
 
Cancer is the #1 diagnosis for hospice admission (28%), ranking third (behind dementia and cardiac/circulatory diagnosis) for Medicare hospice spending. (NHPCA, 2015) Today, 66% of cancer patients live at least 5 years after diagnosis, up from about 50% in the 1970s. (American Cancer Society, 2017)

Dr. Ileana Leyva is regional medical director of VITAS Healthcare for Florida and Georgia. For more information about VITAS Healthcare, visit VITAS.com or call (866) 759-6695.

 
Share |